These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22418883)

  • 1. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research.
    Kleiner DE; Brunt EM
    Semin Liver Dis; 2012 Feb; 32(1):3-13. PubMed ID: 22418883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
    Younossi ZM; Gramlich T; Liu YC; Matteoni C; Petrelli M; Goldblum J; Rybicki L; McCullough AJ
    Mod Pathol; 1998 Jun; 11(6):560-5. PubMed ID: 9647594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Brunt EM; Janney CG; Di Bisceglie AM; Neuschwander-Tetri BA; Bacon BR
    Am J Gastroenterol; 1999 Sep; 94(9):2467-74. PubMed ID: 10484010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.
    Africa JA; Behling CA; Brunt EM; Zhang N; Luo Y; Wells A; Hou J; Belt PH; Kohil R; Lavine JE; Molleston JP; Newton KP; Whitington PF; Schwimmer JB;
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):438-446.e1. PubMed ID: 28286193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: what the pathologist can tell the clinician.
    Brunt EM
    Dig Dis; 2012; 30 Suppl 1():61-8. PubMed ID: 23075870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease.
    Bedossa P;
    Hepatology; 2014 Aug; 60(2):565-75. PubMed ID: 24753132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological assessment of non-alcoholic fatty liver disease.
    Hübscher SG
    Histopathology; 2006 Nov; 49(5):450-65. PubMed ID: 17064291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.
    Kleiner DE; Makhlouf HR
    Clin Liver Dis; 2016 May; 20(2):293-312. PubMed ID: 27063270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology, grading and staging of nonalcoholic fatty liver disease.
    Kleiner DE
    Minerva Gastroenterol Dietol; 2018 Mar; 64(1):28-38. PubMed ID: 28948754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease.
    Bedossa P; Patel K
    Gastroenterology; 2016 Jun; 150(8):1811-1822.e4. PubMed ID: 27003601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Brown GT; Kleiner DE
    Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histologic spectrum of nonalcoholic fatty liver disease.
    Contos MJ; Choudhury J; Mills AS; Sanyal AJ
    Clin Liver Dis; 2004 Aug; 8(3):481-500, vii. PubMed ID: 15331059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.
    Boursier J; Chaigneau J; Roullier V; Lainé F; Sandrini J; Michalak S; Hubert I; Dib N; Oberti F; Bertrais S; Hunault G; Deugnier Y; Rousselet MC; Cavaro-Ménard C; Gallois Y; Aubé C; Calès P;
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):974-81. PubMed ID: 21904208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery.
    Ziolkowski A; Wylezol M; Kukla M; Zwirska-Korczala K; Berdowska A; Pardela M; Gabriel A
    Obes Surg; 2005 Oct; 15(9):1309-14. PubMed ID: 16259893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of nonalcoholic fatty liver disease.
    Brunt EM
    Nat Rev Gastroenterol Hepatol; 2010 Apr; 7(4):195-203. PubMed ID: 20195271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology.
    Gawrieh S; Knoedler DM; Saeian K; Wallace JR; Komorowski RA
    Ann Diagn Pathol; 2011 Feb; 15(1):19-24. PubMed ID: 21106424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of nonalcoholic steatohepatitis.
    Brunt EM
    Hepatol Res; 2005 Oct; 33(2):68-71. PubMed ID: 16214395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
    Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S
    Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.